Microvascular disease and severe COVID-19 outcomes in UKBiobank participants with diabetes
Acta Diabetologica · 2024
DOI: 10.1007/s00592-024-02420-z ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Diabetologica, 2024. Verfasst von Claire Tochel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, EH16 4UX, UK. ctochel@ed.ac.uk. Hauptthemen laut MEDLINE: COVID-19, Diabetic Retinopathy, Diabetes Mellitus, Diabetic Angiopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes UK.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Early in the COVID-19 pandemic, evidence emerged suggesting that people with diabetic retinopathy (DR) or other microvascular diseases had greater risk of severe short-term outcomes. This study evaluated longer-term outcomes, providing more generalisable evidence.
Methods
We identified a cohort of UKBiobank participants with diabetes and retrieved their diagnostic codes for a variety of microvascular diseases, complications of diabetes and systemic comorbidities. We investigated relationships between diagnoses and the study outcome: admission to Critical Care or death from COVID-19, taking age, sex and diabetes duration into account. We tested relationships, adding baseline covariates and weighting diagnostic codes according to their recency prior to COVID-19 diagnosis.
Results
In univariate analyses, DR (OR: 1·519, p = 0·016) and microvascular disease (OR: 2·001, p = 0·000) were associated with greater risk of the outcome. In multivariate analyses, as expected, respiratory disease was most strongly associated with the study outcome, microvascular disease second. Adjusting analyses by number of admissions (general health proxy) and weighted diagnostic coding (comorbidity severity at COVID-19 diagnosis indicator), did not improve predictive power of the model.
Conclusions
The presence of microvascular disease in routinely-collected healthcare data predicts risk of COVID-19 severe outcomes, independently of general health, in a cohort of people with diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, EH16 4UX, UK. ctochel@ed.ac.uk.
- Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, EH16 4UX, UK.
- Centre for Clinical Brain Sciences, Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB, UK.
- Princess Alexandra Eye Pavilion, NHS Lothian, Chalmers St, Edinburgh, EH3 9HA, UK.
- MRC Human Genetics Unit, University of Edinburgh, Edinburgh, EH4 2XU, UK.
- The Bayes Centre, University of Edinburgh, Edinburgh, EH8 9BT, UK.
Förderung
- Diabetes UK
Zitieren
APA
Tochel, C., Engelmann, J., Giarratano, Y., Dhillon, B., Megaw, R., & Bernabeu, M. O. (2024). Microvascular disease and severe COVID-19 outcomes in UKBiobank participants with diabetes. Acta Diabetologica. https://doi.org/10.1007/s00592-024-02420-z
Vancouver
Tochel C, Engelmann J, Giarratano Y, Dhillon B, Megaw R, Bernabeu MO. Microvascular disease and severe COVID-19 outcomes in UKBiobank participants with diabetes. Acta Diabetologica. 2024. doi:10.1007/s00592-024-02420-z
BibTeX
@article{Tochel2024,
author = {Tochel, Claire and Engelmann, Justin and Giarratano, Ylenia and Dhillon, Baljean and Megaw, Roly and Bernabeu, Miguel O},
title = {Microvascular disease and severe COVID-19 outcomes in UKBiobank participants with diabetes},
journal = {Acta Diabetologica},
year = {2024},
doi = {10.1007/s00592-024-02420-z}
}
EUVIMED